RICHARD C JR PFENNIGER
CIK 1200796 · CEO and President · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.67M
Companies
12
Total Filings
162
Lifetime Open-Market Net
$421.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGS | Director | 45,082 | $81.74 | $3.69M | $0 | 1 | 2026-06-23 |
| OPK | Director | 325,000 | $1.39 | $451.7K | $256.2K | 28 | 2026-06-22 |
| FLNT | Director | 120,438 | $4.12 | $496.2K | $0 | 6 | 2026-06-18 |
| COCP | Director | 31,400 | $1.08 | $33.9K | $41.1K | 7 | 2026-01-13 |
| WGSWW | Director | 41,506 | $0.00 | $8 | $69.9K | 10 | 2025-06-23 |
| ASENSUS SURGICAL, INC. (ASXC) Delisted | Director | 0 | $0.35 | $0 | $0 | 5 | 2024-08-22 |
| GeneDx Holdings Corp. (SMFRW) Delisted | Director | — | $0.02 | — | $0 | 2 | 2022-05-06 |
| GP STRATEGIES CORP (GPX) Delisted | Director | 56,297 | $20.85 | $1.17M | $0 | 55 | 2021-10-04 |
| BioCardia, Inc. (BCDAW) Delisted | Director | 48,845 | $0.01 | $298 | $0 | 7 | 2021-01-05 |
| ASENSUS SURGICAL, INC. (TRXC) Delisted | Director | 76,232 | $4.08 | $311.0K | $54.0K | 9 | 2021-01-05 |
| BCDA | Director | 476 | $0.93 | $444 | $0 | 3 | 2018-09-26 |
| CONTINUCARE CORP (CNU) Delisted | CEO and President | 1,415,000 | — | — | $0 | 6 | 2010-09-16 |
Recent Filings · Page 2 of 17
162 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-11 | COCP | Grant (A) | +8,067 | $0 | EDGAR |
| 2024-08-22 | ASENSUS SURGICAL, INC. (ASXC) Delisted | Disp (D) | −189,417 | $0 | EDGAR |
| 2024-07-02 | FLNT | Grant (A) | +21,429 | $0 | EDGAR |
| 2024-06-27 | WGSWW | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | WGSWW | Exer (M) | +5,828 | $0 | EDGAR |
| 2024-05-03 | WGSWW | Exer (M) | +918 | $0 | EDGAR |
| 2024-03-29 | OPK | — | — | $0 | EDGAR |
| 2024-01-05 | OPK | Buy (P) | +25,000 | $23.4K | EDGAR |
| 2023-11-14 | OPK | Buy (P) | +25,000 | $32.5K | EDGAR |
| 2023-11-08 | WGSWW | Buy (P) | +10,000 | $14.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.